3 ms·

There’s no agenda behind it at all. If profits in the US market go down, they either have to go up elsewhere, or investment has to go down to match. This is ver

There’s no agenda behind it at all. If profits in the US market go down, they either have to go up elsewhere, or investment has to go down to match. This is very basic maths.

omegaworks 8y ago
This argument does not at all reflect the actual revenue model of pharmaceutical companies here in the US. In the private sector, far larger amounts of funding are spent on marketing than research[1]. The basic maths shows: investment in research can be maintained or even increased while providing greater access to the fruits of that research. The money is there. What we lack is the proper incentivisation. 1. https://www.washingtonpost.com/news/wonk/wp/2015/02/11/big-pharmaceutical-companies-are-spending-far-more-on-marketing-than-research/?utm_term=.1b16b33608f6 https://www.washingtonpost.com/news/wonk/wp/2015/02/11/big-p...